Envista Holdings (Envista Holdings) ROCE % : -13.68% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Envista Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Envista Holdings's annualized ROCE % for the quarter that ended in Dec. 2023 was -13.68%.

Envista Holdings ROCE % Historical Data

The historical data trend for Envista Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envista Holdings ROCE % Chart

Envista Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

4.45

0.80

5.85

6.02

0.15

Envista Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															6.87	5.38	6.32	3.60	-13.68

Envista Holdings ROCE % Calculation

Envista Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	8.5	/	( ( (6587 - 1236.7)	+	(6605.1 - 780.8) )	/ 2 )
	=	8.5	/	( (5350.3	+	5824.3)	/ 2 )
	=	8.5	/	5587.3
	=	0.15 %

Envista Holdings's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-804.4	/	( ( (6683.8 - 746.8)	+	(6605.1 - 780.8) )	/ 2 )
	=	-804.4	/	( ( 5937	+	5824.3 )	/ 2 )
	=	-804.4	/	5880.65
	=	-13.68 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Envista Holdings (NYSE:NVST) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Envista Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Envista Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Envista Holdings (Envista Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envista Holdings Corp (NYSE:NVST) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

0HV:Germany 0HV:Germany

Address

200 S. Kraemer Boulevard, Building E, Brea, CA, USA, 92821

Website

https://www.envistaco.com

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.

Executives

Eric Conley	officer: SVP, Orthodontics	200 S. KRAEMER BLVD, BLDG E, BREA CA 92821
Mark E Nance	officer: Senior Vice President, GC, Sec	1333 S SPECTRUM BLVD #100, CHANDLER AZ 85286
Stephen Keller	officer: Principal Financial Officer	200 S. KRAEMER BLVD., BUILDING E, BREA CA 92821
Amir Aghdaei	director, officer: PRESIDENT AND CEO	C/O CREDENCE SYSTEMS CORPORATION, 1421 CALIFORNIA CIRCLE, MILPITAS CA 95035
Faez C Kaabi	officer: Chief Accounting Officer	200 S. KRAEMER BLVD., BUILDING E, BREA CA 92821
Howard H Yu	officer: SENIOR VICE PRESIDENT, CFO	250 S. KRAEMER BLVD., BREA CA 92821
Mischa Reis	officer: SENIOR VICE PRESIDENT	C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD, BLDG. E, BREA CA 92821
Curt W Bludworth	officer: SENIOR VICE PRESIDENT, CHRO	250 S. KRAEMER BLVD., BREA CA 92821
Barbara B. Hulit	director	C/O FORTIVE CORPORATION, 6920 SEAWAY BLVD, EVERETT WA 98203
Jeffrey Kappler	officer: SENIOR VICE PRESIDENT	C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD, BLDG. E, BREA CA 92821
Teresa Gayle Sheppard	director	C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA CA 92821
Vivek Jain	director	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Jean-claude Kyrillos	officer: Senior Vice President	C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA CA 92821
Kieran Gallahue	director	PO BOX 684369, PARK CITY UT 84068
William K Daniel	director	2135 WEST MAPLE ROAD, TROY MI 48084